Healthcare AI startup Agamon secures $3M in seed fundingFeaturing FIBA company Agamon.
WHAT THEY DO
Agamon’s AI software uses a natural language understanding solution to structure clinical texts so that hospital computers can read doctors’ unique language. This transforms medical text into data which can be analysed and used to automate patient follow-ups.
The technology is already being used at a number of hospitals in the US, Israel and the UK.
WHAT IT’S FOR
Agamon says it plans to use the funding to scale their deployments with more hospitals globally, further train the AI and widen its clinical spectrum.
Dr Ran Balicer, chief innovation officer of Israel’s largest healthcare organisation, Clalit Research Institute, recently spoke at HIMSS20 Digital about how Israel is using AI to move towards proactive care.
One example is Israel-based startup Ibex Medical Analytics, which announced in December that its AI-powered cancer diagnostics would be deployed at the country’s Maccabi’s pathology institute.
ON THE RECORD
Michal Meiri, CEO and cofounder of Agamon, said: “The inability of today’s computers to understand doctors’ unique way of writing has been a major issue. Doctors can correctly describe an ‘infiltrating mass’ without writing the word ‘tumour’ or write ‘bilateral ground glass peripheral opacity’ without explicitly indicating a suspicion for COVID-19.
Read the full article on Mobi Health News here.